title: Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.
abstract: Despite recent progress in the development of direct-acting antiviral agents against hepatitis C virus (HCV), more effective therapies are still urgently needed. We and others previously identified three phenothiazine compounds as potent HCV entry inhibitors. In this study, we show that phenothiazines inhibit HCV entry at the step of virus-host cell fusion, by intercalating into cholesterol-rich domains of the target membrane and increasing membrane fluidity. Perturbation of the alignment/packing of cholesterol in lipid membranes likely increases the energy barrier needed for virus-host fusion. A screening assay based on the ability of molecules to selectively increase the fluidity of cholesterol-rich membranes was subsequently developed. One compound that emerged from the library screen, topotecan, is able to very potently inhibit the fusion of liposomes with cell culture-derived HCV (HCVcc). These results yield new insights into HCV infection and provide a platform for the identification of new HCV inhibitors.
authors.affiliation: Artie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, Texas, USA.
authors.forename: Ana M
authors.initials: AM
authors.lastname: Chamoun-Emanuelli
authors.forename: Eve-Isabelle
authors.initials: EI
authors.lastname: Pecheur
authors.forename: Rudo L
authors.initials: RL
authors.lastname: Simeon
authors.forename: Da
authors.initials: D
authors.lastname: Huang
authors.forename: Paul S
authors.initials: PS
authors.lastname: Cremer
authors.forename: Zhilei
authors.initials: Z
authors.lastname: Chen
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000737:chemistry / Q000187:drug effects*; D002784:Cholesterol; D057809:HEK293 Cells; D016174:Hepacivirus / Q000187:drug effects* / Q000378:metabolism / Q000472:pathogenicity; D022781:Hepatocytes / Q000821:virology; D006801:Humans; D008560:Membrane Fluidity / Q000187:drug effects*; D010640:Phenothiazines / Q000494:pharmacology*; D053586:Virus Internalization / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D010640:Phenothiazines; D002784:Cholesterol